Back
BioLine Rx Stock Price Chart
Sponsored
BLRX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
BLRX
BioLine Rx
Last Price:
0.33
Seasonality Move:
-0.3%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight buying pressure.
BioLine Rx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.45 | Buy |
50-day SMA: | 0.51 | Buy |
200-day SMA: | 0.73 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.47 | Buy |
50-day EMA: | 0.51 | Buy |
200-day EMA: | 0.75 | Sell |
BioLine Rx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 66.23 | Buy |
Chaikin Money Flow: | 37412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.42 - 0.48) | Buy |
Bollinger Bands (100): | (0.48 - 0.74) | Sell |
BioLine Rx Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioLine Rx Stock
Is BioLine Rx Stock a Buy?
- BioLine Rx share price is 0.55 while BLRX 8-day simple moving average is 0.48, which is a Buy signal.
- The stock price of BLRX is 0.55 while BioLine Rx 20-day SMA is 0.45, which makes it a Buy.
- BioLine Rx 50-day simple moving average is 0.51 while BLRX share price is 0.55, making it a Buy technically.
- BLRX stock price is 0.55 and BioLine Rx 200-day simple moving average is 0.73, creating a Sell signal.
BLRX Technical Analysis vs Fundamental Analysis
Buy
71
BioLine Rx (BLRX)
is a Buy
Is BioLine Rx a Buy or a Sell?
-
BioLine Rx stock is rated a Buy
The current BioLine Rx [BLRX] share price is $0.55. The Score for BLRX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
BioLine Rx Stock Info
Market Cap:
43.59M
Price in USD:
0.55
Share Volume:
346.06K
BioLine Rx 52-Week Range
52-Week High:
1.89
52-Week Low:
0.39
Buy
71
BioLine Rx (BLRX)
is a Buy
BioLine Rx Share Price Forecast
-
What is the BioLine Rx stock price today?
The BioLine Rx stock price is 0.55 USD today. -
Will BLRX stock go up or go down?
BioLine Rx> share price is forecast to RISE/FALL based on technical indicators -
Is BioLine Rx overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioLine Rx is not overvalued.
Is BioLine Rx Stock a Buy?
- BioLine Rx share price is 0.55 while BLRX 8-day exponential moving average is 0.49, which is a Buy signal.
- The stock price of BLRX is 0.55 while BioLine Rx 20-day EMA is 0.47, which makes it a Buy.
- BioLine Rx 50-day exponential moving average is 0.51 while BLRX share price is 0.55, making it a Buy technically.
- BLRX stock price is 0.55 and BioLine Rx 200-day simple moving average is 0.75, creating a Sell signal.
Fundamental Analysis of BioLine Rx
Is BioLine Rx a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
Technical Analysis of BioLine Rx
Should I short BioLine Rx stock?
- BLRX Moving Average Covergence Divergence (MACD) indicator is 0, suggesting BioLine Rx is a Buy
- BioLine Rx Relative Strength Index (RSI) is 66.23, which suggest BioLine Rx is overbought
- The Bollinger Bands (25) for BioLine Rx is (0.42 - 0.48), which suggest BioLine Rx is a Sell
- The Bollinger Bands (100) for BioLine Rx is (0.48 - 0.74), which suggest BioLine Rx is a Sell
* BioLine Rx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.